Ratings AMOREPACIFIC Group

Equities

A002790

KR7002790004

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
35,050 ^KRW	+5.41%		+4.32%	+19.83%

May. 01	Amorepacific Group Posts 10% Decline in Q1 Profit	MT
Mar. 07	AMOREPACIFIC Group Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
The company is in a robust financial situation considering its net cash and margin position.
The stock, which is currently worth 2024 to 675.77 times its sales, is clearly overvalued in comparison with peers.
The company's share price in relation to its net book value makes it look relatively cheap.
The company has a low valuation given the cash flows generated by its activity.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
For the past twelve months, EPS forecast has been revised upwards.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

The company is not the most generous with respect to shareholders' compensation.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Personal Products

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
AMOREPACIFIC GROUP	+19.83%	2.07B		B+
L'ORÉAL	+0.62%	261B		B-
KAO CORPORATION	+19.64%	20.69B		B+
GALDERMA GROUP AG	0.00%	18.4B	-	-
SHISEIDO COMPANY, LIMITED	+6.07%	11.56B		A-
COTY INC.	-10.06%	9.69B		A-
AMOREPACIFIC CORPORATION	+17.79%	7.66B		B+
PROYA COSMETICS CO.,LTD.	+14.08%	6.19B		B
NATURA &CO HOLDING S.A.	+2.13%	4.62B		B+
INTER PARFUMS, INC.	-15.27%	3.91B		C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes